Association of symptoms and cytokines in prostate cancer patients receiving radiation treatment

Biological Research for Nursing

Volumn 16, Issue 3, 2014, Pages 250-257

  Dirksen, Shannon Ruff ^a   Kirschner, Kenneth Ferris ^b   Belyea, Michael J ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cancer; Cytokines; Prostate; Symptoms

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; BLOOD; HUMAN; LONGITUDINAL STUDY; MALE; PROSTATIC NEOPLASMS; QUESTIONNAIRE; STATISTICS;

AGED; CYTOKINES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; PROSTATIC NEOPLASMS; STATISTICS AS TOPIC; SURVEYS AND QUESTIONNAIRES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905021709     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413490228     Document Type: Article

References (50)

1. Ahlberg, K., Ekman, T., & Gaston-Johansson, F. (2004). Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: A pilot study. Biological Research for Nursing, 5, 203-210.
2. American Cancer Society. (2013). Cancer facts and figures 2013.
3. Atlanta, GA: Author. Arend, W. (2002). The balance between IL-1 and IL-1ra in disease. Cytokine & Growth Factor Reviews, 13, 323-340.
4. Aubert, A., Vega, C., Dantzer, R., & Goodall, G. (1995). Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain, Behavior, and Immunity, 9, 129-148.
5. Bastien, C. H., Vallieres, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.
6. Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52, 69-77.
7. Bower, J., Ganz, P., Tao, M., Hu, W., Belin, T., & Sepah, S.,. Aziz, N. (2009). Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research, 15, 5534-5540.
8. Bower, J. E., Ganz, P. A., Aziz, N., Olmstead, R., Irwin, M. R., & Cole, S. W. (2007). Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids. Brain, Behavior, and Immunity, 21, 251-258.
9. Brandeis, J. M., Litwin, M. S., Burnison, C. M., & Reiter, R. E. (2000). Quality of life outcomes after brachytherapy for early stage prostate cancer. Journal of Urology, 163, 851-857.
10. Burgos, I., Richter, L., Klein, T., Fiebich, B., Feige, B., & Lieb, K.,. Riemann, D. (2006). Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study. Brain, Behavior, and Immunity, 20, 246-253.
11. Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., & Meyers, C. A.,. Lee, B. N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919-2925.
12. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum.
13. Dantzer, R., Capuron, L., Irwin, M. R., Miller, A. H., Ollat, H., & Perry, V. H.,. Yirmiya, R., (2008). Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology, 33, 18-29.
14. Dirksen, S., Epstein, D., & Hoyt, M. (2009). Insomnia, depression and distress among outpatients with prostate cancer. Applied Nursing Research, 22, 154-158.
15. Fitch, M. I., Gray, R., Franssen, E., & Johnson, B. (2000). Men's perspectives on the impact of prostate cancer. Implications for oncology nurses. Oncology Nursing Forum, 27, 1255-1263.
16. Geinitz, H., Zimmermann, F., Stoll, P., Thamm R., Kaffenberger, W., & Ansorg, K.,. Molls, M. (2001). Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. International Journal of Radiation Oncology*Biology* Physics, 51, 691-698.
17. Geinitz, H., Zimmermann, F. B., Thamm, R., Keller, M., Busch, R., & Molls, M. (2004). Fatigue in patients with adjuvant radiation therapy for breast cancer: Long-term follow-up. Journal of Cancer Research and Clinical Oncology, 130, 327-333.
18. Greenberg, D. B., Gray, J. L., Mannix, C. M., Eisenthal, S., & Carey, M. (1993). Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management, 8, 196-200.
19. Hervouet, S., Savard, J., Simard, S., Ivers, H., Laverdiére, J., & Vigneault, E.,. Lacombe, L. (2005). Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. Journal of Pain and Symptom Management, 30, 474-484.
20. Jehn, C., Kuehnhardt, D., Bartholomae, A., Jehn, C., Kuehnhardt, D., & Pfeiffer, S.,. Flath, B. C. (2006). Biomarkers of depression in cancer patients. Cancer, 107, 2723-2729.
21. Khan, S. S., Smith, M. S., Reda, D., Suffredini, A. F., & McCoy, J. P. (2004). Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry Part B: Clinical Cytometry, 61B, 35-39.
22. Kovacs, C., Daly, B., Evans, M., Johnke, R., Lee, T., & Karlsson, U.,. Biggs, L. (2003). Cytokine profiles in patients receiving wide-field and prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine, 23, 151-163.
23. Lee, S. O., Chun, J., Nadiminty, N., Lou, W., Feng, S., & Gao, A. C. (2009). IL-4 activates androgen receptor through CBP/p300. Prostate, 1, 126-132.
24. Li, H., Hodgson, E., Watson, L., Shukla, A., & Nelson, J. (2012). Comorbidities and concomitant medication use in men with prostate cancer or high levels of PSA compared to matched controls: A GPRD analysis. Journal of Cancer Epidemiology, 2012, 1-32.
25. Lopes, C., & Callera, F. (2012). Three-dimensional conformal radiotherapy in prostate cancer patients: Rise in interleukin 6 (IL-6) but not in IL-2, IL-4, IL-5, tumor necrosis factor-a, MIP-1-a and LIF levels (2011). International Journal of Radiation Oncology*Biology*- Physics, 82, 1385-1388.
26. Lyon, D., Walter, J., Munro, C., Schubert, C., & McCain, N. (2011). Challenges in interpreting cytokine biomarkers in biobehavioral research: A breast cancer exemplar. Biological Research for Nursing, 13, 25-31.
27. Maes, M. (1995). Evidence for an immune response in major depression: Areviewand hypothesis. Progress inNeuro-Psychopharmacology& Biological Psychiatry, 19, 11-38.
28. McNair, D., Lorr, M., & Droppleman, L. (1971). Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service. Miaskowski, C., & Aouizerat, B. (2012). Biomarkers: Symptoms, survivorship, and quality of life. Seminars in Oncology Nursing, 28, 129-138.
29. Monga, U., Kerrigan, A. J., Thornby, J., & Monga, T. (1999). Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiation Oncology Investigations, 7, 178-185.
30. Moorey, S., Greer, S., Watson, M., Gorman, C., Rowden, L., & Tunmore, R.,. Bliss, J. (1991). The factor structure and factor stability of the Hospital anxiety and depression scale in patients with cancer. British Journal of Psychiatry, 158, 255-259.
31. Morin, C. M. (1993). Insomnia: Psychological assessment and management. New York, NY: Guilford Press.
32. Musselman, D., Miller, A., Porter, M., Manatunga, A., Gao, F., & Penna, S.,. Nemeroff, C. (2001). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry, 158, 1252-1257.
33. Opal, S. M., & DePalo, V. A. (2000). Anti-inflammatory cytokines. Chest, 117, 1162-1172.
34. Quatan, N., Meyer, B., Bailey, M., & Pandha, H. (2006). Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy. Prostate Cancer and Prostatic Diseases, 9, 420-425.
35. Richins, J. L., Urbanowicz, R. A., Metcalf, R., Corne, J., O'Shea, P., & Fairclough, L. (2010). Quantitative validation and comparison of multiplex cytokine kits. Journal of Biomolecular Screening, 15, 562-568.
36. Satariano, W.A., Ragheb, N. E., & Dupuis, M. H. (1989).Comorbidity in older women with breast cancer: An epidemiologic approach. In R. Yancik &J. Yates (Eds.), Cancer in the elderly: Approaches to early detection and treatment (pp. 71-107). New York, NY: Springer.
37. Schubert, C., Hong, S., Natarajan, L., Mills, P. J., & Dimsdale, J. E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21, 413-427.
38. Sothern, R. B., Roitman-Johnson, B., Kanabrocki, E. L., Yager, J. G., Fuerstenberg, R. K., & Weatherbee, J. A.,. Schering, L. E. (1995). Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo, 9, 331-339.
39. Soygur, H., Palaoglu, O., Akarsu, E. S., Cankurtaran, E. S., Ozalp, E., Turhan, L., & Ayhan, I. H. (2007). Interleukin-6 and HPA axis activation in breast cancer patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1242-12477.
40. Steptoe, A., Hamer, M., & Chida, Y. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity, 21, 901-912.
41. Talluri, G., Marella, V., Shirazian, D., & Wise, G. (2000). Immune response in patients with hormone treated prostate cancer. Journal of the American College of Surgeons, 191, S94.
42. van Andel, G., & Kurth, K. H. (2003). The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. European Urology, 44, 209-214.
43. Vgontzas, A. N., Zoumakis, M., Papanicolaou, D. A., Bixler, E. O, Prolo, P., & Lin, H. -M.,. Chrousos, G. P. (2002). Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism, 51, 887-892.
44. Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000). Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56, 899-905.
45. Wei, J. T., Dunn, R. L., Sandler, H. M., McLaughlin, P. W., Montie, J. E., & Litwin, M. S.,. Sanda, M. G. (2002). Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. Journal of Clinical Oncology, 20, 557-566.
46. Wise, G., Marella, V., Talluri, G., & Shirazian, D. (2000). Cytokine variations in patients with hormone treated prostate cancer. Journal of Urology, 164, 722-725.
47. Yeh, H. C., Liu, C. C., Lee, Y. C., Wu, W. J., Li, W. M., & Li, C. C.,. Huang, S. P. (2012). Associations of the lower urinary tract symptoms with the lifestyle, prostate volume, and metabolic syndrome in the elderly males. Aging Male, 15, 166-172.
48. Young, M. R., Matthews, J. P., Kanabrocki, E. L., Sothern, R. B., Roitman- Johnson, B., & Scheving, L. E. (1995). Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factoralpha, and granulocyte-macrophage colony-stimulating factor in men. Chronobiology International, 12, 19-27.
49. Zhou, X., Fragala, M. S., McElhaney, J. E., & Kuchel, G. A. (2010). Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Current Opinion in Clinical Nutrition & Metabolic Care, 13, 541-547.
50. Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.